{"id":"W3211800240","doi":"10.2217/cer-2021-0221","title":"Palbociclib versus abemaciclib in HR+/HER2- advanced breast cancer: an indirect comparison of patient-reported end points","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Fulvestrant; Nausea; Breast cancer; Quality of life (healthcare); Internal medicine; Oncology; Palbociclib; Cancer; Metastatic breast cancer; Estrogen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003811605,0.0008442091,0.00168584,0.0005255197,0.0001190028,0.0007499462,0.0005489523,0.0005663114,0.004749548],"category_scores_gemma":[0.005651121,0.0002608362,0.003122027,0.0005189343,0.0003782584,0.0006030196,0.0007598375,0.001332329,0.0002875912],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007463191,"about_ca_system_score_gemma":0.0004986169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009461435,"about_ca_topic_score_gemma":0.001551807,"domain_scores_codex":[0.9963743,0.002855082,0.0001605318,0.0001898548,0.0002801076,0.0001400311],"domain_scores_gemma":[0.9972971,0.001675506,0.0006897058,0.000117108,0.00007956362,0.0001411356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.866585,0.002348843,0.02772597,0.004195225,0.03395601,0.00006321594,0.0001007706,0.002703789,0.001173043,0.0004899121,0.0006225692,0.06003561],"study_design_scores_gemma":[0.3213947,0.3247675,0.2481789,0.001124345,0.07797033,0.0005782105,0.0004992359,0.01257017,0.004351393,0.001957757,0.006460216,0.0001472707],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825845,0.01271197,0.0005664416,0.0002365012,0.0001798012,0.0003748529,0.00114644,0.00001850356,0.002181061],"genre_scores_gemma":[0.9965553,0.001457346,0.0004556659,0.0001235499,0.00007085198,0.0003042496,0.0005301014,0.000003875618,0.0004991022],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004749548,"threshold_uncertainty_score":0.02015799,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1333659944022162,"score_gpt":0.5031046785495277,"score_spread":0.3697386841473115,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}